Published in Neurobiol Aging on February 26, 2007
Vitamin D-related Genes and Metabolic Disorders | NCT03279432
Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res (2008) 2.95
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab (2012) 2.76
Insulin regulates brain function, but how does it get there? Diabetes (2014) 1.56
PET imaging of leptin biodistribution and metabolism in rodents and primates. Cell Metab (2009) 1.47
Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS (2011) 1.33
Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem (2008) 1.23
Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J Neurochem (2008) 1.04
Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS (2011) 0.97
LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease. Front Physiol (2012) 0.96
Afamin is synthesized by cerebrovascular endothelial cells and mediates alpha-tocopherol transport across an in vitro model of the blood-brain barrier. J Neurochem (2008) 0.96
Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function. PLoS One (2011) 0.96
Treadmill exercise alleviates impairment of spatial learning ability through enhancing cell proliferation in the streptozotocin-induced Alzheimer's disease rats. J Exerc Rehabil (2014) 0.95
Serum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey. Neurobiol Aging (2011) 0.94
Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. BMC Neurol (2010) 0.93
Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approaches. Front Pharmacol (2012) 0.91
Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease. J Alzheimers Dis (2011) 0.91
Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins. J Biol Inorg Chem (2011) 0.90
Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway. Nat Commun (2013) 0.89
Mouse models of neurological disorders: a view from the blood-brain barrier. Biochim Biophys Acta (2009) 0.88
Clusterin/ApoJ enhances central leptin signaling through Lrp2-mediated endocytosis. EMBO Rep (2014) 0.86
Brain renin-angiotensin system in the nexus of hypertension and aging. Hypertens Res (2012) 0.86
New pharmacological perspectives for the leptin receptor in the treatment of obesity. Front Endocrinol (Lausanne) (2014) 0.86
Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr (2011) 0.86
Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus. J Am Heart Assoc (2014) 0.84
Whole exome sequencing of extreme morbid obesity patients: translational implications for obesity and related disorders. Genes (Basel) (2014) 0.84
Gelsolin restores A beta-induced alterations in choroid plexus epithelium. J Biomed Biotechnol (2010) 0.83
Age-Associated Weight Gain, Leptin, and SIRT1: A Possible Role for Hypothalamic SIRT1 in the Prevention of Weight Gain and Aging through Modulation of Leptin Sensitivity. Front Endocrinol (Lausanne) (2015) 0.81
The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epithelium. BMC Neurosci (2011) 0.81
New insights in the amyloid-Beta interaction with mitochondria. J Aging Res (2012) 0.81
Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling. Brain Behav Immun (2014) 0.80
Dynamic expression of Dab2 in the mouse embryonic central nervous system. BMC Dev Biol (2008) 0.80
In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein. Front Aging Neurosci (2016) 0.80
Improved leptin sensitivity as a potential candidate responsible for the spontaneous food restriction of the Lou/C rat. PLoS One (2013) 0.79
Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. Cell Mol Neurobiol (2016) 0.77
Vitamin D receptor and megalin gene polymorphisms are associated with central adiposity status and changes among US adults. J Nutr Sci (2013) 0.77
The effect of aging on brain barriers and the consequences for Alzheimer's disease development. Mamm Genome (2016) 0.77
Dynamic changes in leptin distribution in the progression from ovum to blastocyst of the pre-implantation mouse embryo. Reproduction (2011) 0.76
Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer's Disease Patients. Front Cell Neurosci (2015) 0.76
The choroid plexus-cerebrospinal fluid interface in Alzheimer's disease: more than just a barrier. Neural Regen Res (2016) 0.76
Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression. J Alzheimers Dis (2016) 0.75
Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia. Int J Alzheimers Dis (2011) 0.75
Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin. J Neuroinflammation (2017) 0.75
The Leptin Receptor Complex: Heavier Than Expected? Front Endocrinol (Lausanne) (2017) 0.75
Gut-brain communications: not the same at all ages. Endocrinology (2010) 0.75
Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain. Histochem Cell Biol (2015) 0.75
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Brain (2010) 1.77
Molecular findings in familial Parkinson disease in Spain. Arch Neurol (2002) 1.43
Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci (2005) 1.40
Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med (Berl) (2003) 1.22
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation (2012) 1.15
Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol (2005) 1.14
Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease? Neurobiol Aging (2005) 1.09
A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy. Arch Neurol (2005) 1.04
Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease. J Alzheimers Dis (2011) 1.02
Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J Cell Sci (2009) 0.99
Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res (2004) 0.97
Drug-induced parkinsonism. Expert Opin Drug Saf (2013) 0.93
Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. BMC Neurol (2010) 0.93
Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approaches. Front Pharmacol (2012) 0.91
Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Dis (2009) 0.91
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Ann Neurol (2005) 0.91
Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease. Neurochem Res (2006) 0.90
Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol Cell Neurosci (2010) 0.90
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials (2010) 0.89
Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol Aging (2008) 0.89
Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol (2009) 0.89
Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice. Hum Mol Genet (2008) 0.88
Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease. BMC Neurol (2010) 0.87
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiol Aging (2013) 0.85
Mortality, oxidative stress and tau accumulation during ageing in parkin null mice. J Neurochem (2007) 0.85
Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J Neurophysiol (2003) 0.84
Gelsolin restores A beta-induced alterations in choroid plexus epithelium. J Biomed Biotechnol (2010) 0.83
Progressive nonfluent aphasia associated with a new mutation V363I in tau gene. Am J Alzheimers Dis Other Demen (2007) 0.83
Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer's disease. Cell Mol Life Sci (2013) 0.83
PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer's disease. J Alzheimers Dis (2010) 0.82
A zoonotic ringworm outbreak caused by a dysgonic strain of Microsporum canis from stray cats. Rev Iberoam Micol (2010) 0.82
On the diagnosis of CADASIL. J Alzheimers Dis (2009) 0.82
Sedentary life impairs self-reparative processes in the brain: the role of serum insulin-like growth factor-I. Rev Neurosci (2002) 0.81
The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice. Exp Neurol (2009) 0.81
The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epithelium. BMC Neurosci (2011) 0.81
Drug-induced parkinsonism. Expert Opin Drug Saf (2006) 0.81
tPA in the central nervous system: relations between tPA and cell surface LRPs. Recent Pat Endocr Metab Immune Drug Discov (2013) 0.80
Present and future of adeno associated virus based gene therapy approaches. Recent Pat Endocr Metab Immune Drug Discov (2012) 0.80
Choroid plexus implants rescue Alzheimer's disease-like pathologies by modulating amyloid-β degradation. Cell Mol Life Sci (2013) 0.80
Prevention of senescence progression in reversibly immortalized human ensheathing glia permits their survival after deimmortalization. Mol Ther (2009) 0.80
IGF-I gene variability is associated with an increased risk for AD. Neurobiol Aging (2010) 0.80
A megalin polymorphism associated with promoter activity and Alzheimer's disease risk. Am J Med Genet B Neuropsychiatr Genet (2010) 0.80
Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease. PLoS One (2013) 0.80
G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients. Mol Neurobiol (2014) 0.79
Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1). J Alzheimers Dis (2012) 0.79
Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease. Neurobiol Dis (2012) 0.79
What is the impact of education on Huntington's disease? Mov Disord (2011) 0.79
Effects of partial suppression of parkin on huntingtin mutant R6/1 mice. Brain Res (2009) 0.79
Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice. Brain Res (2005) 0.79
VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease. J Control Release (2013) 0.78
Risk of incident dementia in drug-untreated arterial hypertension: a population-based study. J Alzheimers Dis (2010) 0.78
Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)]. Eur J Neurosci (2012) 0.78
Western style diet impairs entrance of blood-borne insulin-like growth factor-1 into the brain. Neuromolecular Med (2007) 0.78
Encapsulated VEGF-secreting cells enhance proliferation of neuronal progenitors in the hippocampus of AβPP/Ps1 mice. J Alzheimers Dis (2012) 0.77
Higher glutamate to glutamine ratios in occipital regions in women with migraine during the interictal state. Headache (2012) 0.77
Understanding care of people with dementia in Spain: cohabitation arrangements, rotation and rejection to long term care institution. Int J Geriatr Psychiatry (2009) 0.76
A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease. Neurotox Res (2009) 0.76
Experimental models for understanding the role of insulin-like growth factor-I and its receptor during development. Adv Exp Med Biol (2005) 0.76
Expression of regulatory proteins in choroid plexus changes in early stages of Alzheimer disease. J Neuropathol Exp Neurol (2015) 0.75
PET-Florbetapir findings in primary cerebral amyloidoma. J Neurol (2015) 0.75
Decline of executive processes affects identification of emotional facial expression in aging. Curr Aging Sci (2011) 0.75
Protocols for Monitoring the Development of Tau Pathology in Alzheimer's Disease. Methods Mol Biol (2016) 0.75